Mumbai, 3 Dec 2020: Serum Institute of India (SII) is likely to begin selling its Covid-19 vaccine in the open market from March-April next year amid substantial demand from big companies which want to buy the jabs in bulk for their employees.

 

“The pr......
View Details

Related News

• Dentist goes into septic shock days after vaccine in AP (28-01-2021)

---

• FSSAI asks state authorities to form helpdesk for smoother licensing & regn (28-01-2021)

---

• GSK transfers malaria vaccine production to Bharat Biotech (28-01-2021)

---

• Mumbai: Eight doctors reject Serum Institute’s Covishield, opt for Covaxin (28-01-2021)

---

• Regulate health e-service aggregators, states told (28-01-2021)

---

• SII seeks govt nod to ‘unblind’ trial data as volunteers ask if they got vaccine or placebo (28-01-2021)

---

• Bharat Biotech’s Covaxin neutralises UK strain of coronavirus: Study (28-01-2021)

---

• WHO issues new clinical advice on treating Covid-19 patients (27-01-2021)

---

• EU warns drug cos of strict export rules amid vax delays (27-01-2021)

---

• Hundreds of undigested pills found in patient's stomach in Kolkata (27-01-2021)

---